A Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 in Patients With Schizophrenia
Clinical trial NCT02720263 · COMPLETED
Trial details
- NCT number
- NCT02720263
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-28
- Primary completion
- 2017-06-08
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.